Fred Kim is the Managing Director of AriBio’s US office, overseeing global clinical and strategic development. With a background that includes significant contributions in program strategy and global clinical operations, Fred previously served as the program director at AriBio, overseeing the development of pipeline focused on neurodegeneration. Prior to his tenure at AriBio, Fred co-founded Memo:Re, a pioneering mobile application designed for individuals with memory decline, showcasing his commitment to innovative solutions in brain health. Fred also serves on the Board of Directors at AriBio and Solux. Fred obtained his Bachelor's degree in Biology from Dartmouth College and has pursued advanced medical education at the Geisel School of Medicine at Dartmouth. His professional journey is underscored by a dedication to improving patient outcomes and advancing research in Alzheimer's and related conditions.